Nike slips after hours as results show soft China sales, gross margin pressure

Nike beat fiscal Q3 estimates with EPS $0.35 vs $0.30 expected and revenue $11.28B vs $11.23B, but gross margin fell 130 bps to 40.2% and Greater China sales declined 7% Y/Y to $1.62B. North America revenue rose 3% to $5.03B; shares slipped ~2.6% after hours amid ongoing China weakness and tariff-driven margin pressure. CEO Elliott Hill’s turnaround (shift from DTC to wholesale and faster product cadence) shows early progress, but the stock has declined ~15.8% in 2025 and ~17.1% YTD, with analysts (Jefferies) calling the risk-reward skewed to the upside despite remaining execution risks.

Analysis

Nike’s near-term share dynamics are now governed less by headline quarterly beats and more by where China demand and channel mix normalize relative to wholesale partners. The more important second-order effect is inventory cadence: cleaner inventories at the brand level can create a multi-quarter trough in supplier orders and mid-tier retail restocking, which favors faster-cycle local manufacturers over long-lead global producers.

Tariff and trade-policy volatility has turned sourcing into an active margin lever rather than a background input cost; one plausible outcome is accelerated supplier diversification away from large OEMs toward nimble regional factories, which compresses Nike’s supplier bargaining power and raises product-cost variability across markets. Currency and platform economics in China amplify this — smaller local brands can flex price and assortment faster, increasing probability of structural share erosion if Nike’s product cadence lag persists.

From a timing perspective, expect market-moving data in three buckets: immediate (days-weeks) — monthly retail reads and commentary from wholesale partners; near-term (1-3 months) — guidance updates and China consumption indicators; medium-term (3-12 months) — observable shifts in orderbooks and supplier footprints. The highest-conviction trade is a relative-position that isolates China/wholesale exposure while hedging global cyclical risk, with options used for defined-risk entry around earnings and tariff headlines.

Key Decisions for Investors

• Pair trade (6-12 months): Long ANTA / Short NKE, equal-dollar notional. Rationale: isolates China-first exposure vs Nike’s multi-market mix; target 20-30% relative outperformance if Chinese demand reaccelerates or local brands continue share gains. Hard stop: 10% adverse move on either leg or if China retail prints materially beat/miss consensus by >5% in same month.
• Defined-risk downside hedge on NKE (0-3 months): Buy a 3-month put spread on NKE (buy near-ATM put, sell ~10% lower strike) to protect against an earnings-guidance shock. Cost = premium; payoff kicks in if NKE falls >10% — expect asymmetric protection if guidance disappoints around tariff/China commentary.
• Leveraged China recovery long (6-12 months): Buy a 6–12 month ANTA call spread to capture upside from accelerating domestic demand and share consolidation, sizing ~3-5% portfolio. Target 2:1 to 3:1 payoff if ANTA re-rates on improving top-line trends; cut exposure if wholesale order data flattens for two consecutive months.
• Contrarian runway trade (12+ months): Small-long NKE via a calendar call or long-dated OTM call to play structural brand and margin recovery if management executes. Keep position size small (1-2% portfolio); exit or convert to stock if consecutive quarters show China stabilization and digital recovery metrics improving.